Related Experiment Video
Updated: Jun 28, 2026
11:24
Transfecting Human Neural Stem Cells with the Amaxa Nucleofector
Published on: July 19, 2007
Transfecting human neural stem cells with the Amaxa Nucleofector
Steven Marchenko1, Lisa Flanagan
1Department of Pathology, University of California, Irvine, USA. smarchen@uci.edu
Journal of Visualized Experiments : Jove
|November 11, 2008
Summary
This study presents an optimized protocol for efficiently transfecting human neural stem/precursor cells (hNSPCs). The new method significantly improves cell viability and transfection rates compared to existing techniques for neural cell gene delivery.
Area of Science:
- Neuroscience
- Molecular Biology
- Biotechnology
Background:
- Transfecting primary mammalian neural cells, including human neural stem/precursor cells (hNSPCs), faces challenges with low cell viability and transfection efficiency using conventional methods.
- Existing techniques like cationic lipid reagents, gene guns, microinjection, and viral vectors have limitations including poor cell survival, low transfection numbers, time-consuming vector preparation, and safety concerns.
Purpose of the Study:
- To develop and present a detailed, optimized protocol for the efficient transfection of hNSPCs.
- To overcome the limitations of current gene delivery methods in primary neural cells.
Main Methods:
- Utilizing Amaxa's Nucleofector device with specifically optimized electrical parameters and buffer solutions for neural stem cells.
- Combining a high density of hNSPCs with the DNA of interest in a specialized buffer before electroporation.
Main Results:
- Achieved initial transfection efficiencies of approximately 35%.
- Attained approximately 70% efficiency after stable transfection, demonstrating significant improvement over existing methods.
Conclusions:
- The described step-by-step protocol offers a robust and efficient method for transfecting hNSPCs.
- This optimized electroporation technique enhances gene delivery into primary neural cells, addressing previous limitations in viability and efficiency.
